logo

Stoke Therapeutics Inc (STOK) Stock: 52-Week Performance Insights and Trading Volume

The 52-week high and low prices can offer valuable insights into a stock’s current standing and prospects for future performance. Stoke Therapeutics Inc’s current trading price is -35.61% away from its 52-week high, while its distance from the 52-week low is 176.77%. The stock’s price range for this period has been between $4.09 and $17.58 The company’s shares, which are part of the Healthcare sector, had a trading volume of approximately 0.52 million for the day, a number notably lower than the average daily volume of 0.59 million over the last three months.

In terms of market performance, Stoke Therapeutics Inc had a fairly even. The highest value for the stock in the past year was $17.58 on 06/13/24, and the lowest value was recorded at $4.09 on 02/13/24.

Exploring Financial Performance and Market Capitalization: A Comprehensive Analysis

Stoke Therapeutics Inc (STOK) has experienced a quarterly decline of -6.90% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 584.61M and boasts a workforce of 110 employees.

Analyzing Trading Volume and Moving Average Trends

Based on Barchart.com data, the company’s moving average over the 100-day period was 13.10, with a change in price of -3.14. Similarly, Stoke Therapeutics Inc recorded 571,677 in trading volume during the last 100 days, posting a change of -21.72%.

Understanding Ticker ‘s Debt-to-Equity Ratio: An Analysis

The debt-to-equity (D/E) ratio serves as an important indicator of a company’s financial stability and market position. By dividing a company’s total liabilities by its shareholders’ equity, the D/E ratio reveals the degree to which a company relies on debt to finance assets compared to its shareholders’ equity. At the time of writing, the total D/E ratio for STOK stands at 0.02. Similarly, the long-term debt-to-equity ratio is also 0.01.

STOK Stock Stochastic Average

As of today, Stoke Therapeutics Inc’s raw stochastic average for the last 50 days stands at 17.27%. This is a decline compared to the raw stochastic average of the previous 20 days, which was noted at 18.81%. Furthermore, the company’s Stochastic %K and %D values for the past 20 days were 24.55% and 22.42%, respectively.

STOK Stock Price Performance Analysis

The stock price performance for the year has been a mixed bag, indicating either a pessimistic or optimistic outlook depending on how you look at it. The metric has seen a significant gain of 125.86% since the start of this calendar year. Looking back over the last six months, we can see a stronger performance of -8.05%. Over the past 30 days, the price of STOK has fallen by 3.94%. And in the last five days, it has fallen by -1.82%.

Most Popular